<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-viruses-12-00518">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Buffin</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Peubez</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Barriere</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Nicolai</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Tapia</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Dhir</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Forma</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Seve</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Legastelois</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies</article-title>
  <source>Vaccine</source>
  <fpage>2019</fpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.09.057</pub-id>
 </element-citation>
</ref>
